Yap, Baby Girl -.
HRN: 24-18-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/28/2023
12/05/2023
IV
35mg
Q24H
Thickly MSAF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes